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In this issue, we present two articles1,2 on an aged topic: why does a person develop lung cancer? An unarguable answer is tobacco smoking exposure, voluntary or involuntary. 
With the knowledge gained on smoking-related harm and tobacco control policy imple-
mented over the past three decades, attention to the causes of lung cancer beyond smoking 
gradually rises from the horizon. Evidence supporting other causes leading to lung can-
cer stems from two main roots: nontobacco smoke-related environmental exposures and 
individual’s intrinsic susceptibility.3,4 Specifically, one rooted from a collection of other 
environmental hazards potentiated from ambient air pollution (outdoor or indoor), diet, 
and occupational exposure to carcinogen-containing material, food, or surrounding space, 
e.g., asbestos and radioactive gas;4 another is from the growing body of studies showing 
genetic predisposition or individual susceptibility underlying high or low risk to develop 
lung cancer.5–7 However, teasing apart the relative importance of genes and environment, 
and the interactions of the two, has been and continues to be a challenge to the researchers 
and all interested parties.6
An important lesson is the overwhelming influence of tobacco smoking when inves-
tigating the genetic effect on lung cancer in people who have smoked cigarettes; results 
on roles of genetic factors are often confounded by the smoking history or nicotine addic-
tion.8 A similar stipulation has been observed from studies of genetic risk factors to lung 
cancer in uranium miners, where the genetic effects, are often overpowered by exposure to 
extremely high levels of radioactive gas and cigarette smoking is a concurrent exposure.9 
On the contrary and in statistical theory, significant interactions can be feasibly tested when 
the main effect of each factor is mild to moderate; whereby investigating the interaction 
between residential radon exposure and individual susceptibility may become a paradigm 
for demonstrating environment and genome interactions in the development and progres-
sion of human diseases. For lung cancer, residential radon exposure has been studied and 
results have been debated for over 30 years.10,11 So, the “lyrics” are not new: Odds ratio (as a 
surrogate measure of risk ratio) for lung cancer increased with residential radon concentra-
tion after on average 20 years exposure, ranging from 1.1 in never smokers (at a concentra-
tion 100 Bq/m3) to 42.3 in smokers (at a concentration 400 Bq/m3); many radon-related 
cancer deaths occur among smokers; and approximately 1 in 10 never smokers who died of 
lung cancer were radon-related.
At a global view of the ecological correlation between age-adjusted lung cancer inci-
dence in men and the matching geographic distribution of residential radon level,12,13 we 
can clearly summarize the following four patterns, as illustrated in Figure 1 from left to 
right: high residential radon and low lung cancer incidence, high residential radon and high 
lung cancer incidence, low residential radon and low lung cancer incidence, and low resi-
dential radon and high lung cancer incidence. No particular trend is observed, which could 
well be explained by not considering tobacco smoking prevalence. On the other hand, using 
the actual measure of residential radon for each individual in either a retrospective case-
control study or a prospective cohort study would provide a more accurate estimate of an 
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alleged cause. However, temporal variation of such measure-
ment could represent a major source of uncertainty or bias;14 
yet multiyear measurements for a potential risk factor with 
long latency time to disease onset have been proven neither 
cost-effective nor feasible for large, mobile populations.
the role of genetic predisposition and individual suscep-
tibility in lung cancer etiology has been long recognized, sup-
ported by the fact—as in another classic “lyrics”—that only a 
minority of long-term heavy smokers would ever develop the 
disease during their lifetime. the search and research for this 
genetic cause (intrinsic or inherited risk) has been ongoing 
for one-half of a century;15 methods used have gone through 
dramatic revolution, from a simple measure of family history 
to sophisticated tests of familial aggregation, pedigree-based 
linkage analysis, and case-control based association stud-
ies. With the rapid advance in genomic technology and new 
knowledge, large-scale epidemiologic studies testing genetic 
effects in etiology of human diseases become feasible, either 
focusing on evidence-based candidate genes and biological 
markers or interrogating the whole genome.
Meanwhile, a significant knowledge gap of nowadays 
etiologic research in lung cancer, beyond tobacco smoking, is 
whether and how strong the hazardous environmental expo-
sures interact with genomic susceptibility to carcinogens. 
the two articles published in this issue are examples of great 
efforts in elucidating whether environmental exposure histo-
ries interact with genetic factors in two distinct approaches.
In the first article, the authors developed novel methods 
to index collective environmental exposures, which deserve 
attention in the research community investigating complex 
interactions among risk factors from multiple dimensions. 
Improvements of these types of studies include accurate mea-
sure of family history, considering number, age, and smoking 
status of the relatives, actual measures of household residen-
tial radon levels of study subjects, and more precise  definitions 
of benign lung diseases and never smokers.
In the second article, a hospital-based case-control 
study demonstrated that absence of two important detoxify-
ing metabolic genes (GSTM1 and GSTT1) increases the risk 
of lung cancer in people who had exposed to higher than 
normal level of residential radon. Noticeable shortcomings of 
these types of studies include testing only one or a few can-
didate genes and inadequate control for residual effect from 
tobacco smoking.
to conclude, a common new “tune” of these two articles 
is that both found residential radon exposure may have dif-
ferential impact on lung cancer risk when taking into account 
individuals’ genetic disposition.
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